SciELO - Scientific Electronic Library Online

 
vol.106 issue4Genetic and molecular mechanisms leading to eosinophilic esophagitisBouveret's syndrome: evaluation with multidetector CT author indexsubject indexarticles search
Home Pagealphabetic serial listing  

My SciELO

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Revista Española de Enfermedades Digestivas

Print version ISSN 1130-0108

Rev. esp. enferm. dig. vol.106 n.4 Madrid Apr. 2014

 

PICTURES IN DIGESTIVE PATHOLOGY

 

Anorectal melanoma associated with colonic metastasis

Melanoma anorrectal asociado a metástasis colónicas

 

 

Macarena Fernández-Albornoz, Joaquín Irarrázaval-Espinoza, Andrés Larach-Kattan and Leonardo Espíndola-Silva

Hospital Militar. Santiago, Chile

 

 

Case report

A 67-year-old female patient with no medical history presents with pain and increased volume in her right lower limb for the last three weeks. She is admitted with a diagnosis of right-side iliac-femoral-popliteal deep venous thrombosis and bilateral pulmonary thromboembolism. She developed rectorrhagia following anticoagulation. Colonoscopy revealed an exophytic, mamillated, friable, anteriorly ulcerated lesion from the anal margin to the mid rectum (Fig. 1), two lesions with similar characteristics in the ascending colon, and three such lesions at the ileocecal valve (Fig. 2). Histopathology and immunohistochemical studies are consistent with melanoma. Abdominal and pelvic CT and MRI scans show a solidly thickened wall with lumpy contours, heterogeneous structure, and poorly delimited borders in the mid and lower rectum, cecum, and ascending colon. She also has neoplastic-looking adenopathies in the right external iliac chain, right hypogastric chain, and aortic bifurcation. The patient received symptomatic palliative care.

 

 

Discussion

Anorectal melanoma represents 0.1 %-4.6 % (3) of anorectal neoplasms, and less than 2 % of all melanomas, with a median survival below 20 months (1). Lower gastrointestinal bleeding is the most common clinical manifestation (55 %) (4). A differential diagnosis with other colorectal neoplasms is difficult to establish with only colonoscopy, hence histological and immunohistochemical confirmation (positivity for HMB-45 and protein S-100) is essential (2). At the time of diagnosis, over 30 % of subjects have distant metastases on CT or MRI images (4). Colonic melanoma metastases represent 22-28 % of all gastrointestinal metastases (3). Surgical resection is used for localized cases; however, survival is related to metastasis development rather than local disease control. The role of chemotherapy is uncertain and radiation therapy is useful for palliation (2,4).

 

References

1. Stefanou A and Nalamati S. Anorectal Melanoma. Clin Colon Rectal Surg 2011;24:171-6.         [ Links ]

2. Meguerditchian A, Meterissian S, Bullard Dunn K. Anorectal melanoma: Diagnosis and treatment. Dis Colon Rectum 2011;54:638-44.         [ Links ]

3. Díaz-Sánchez A, Lara MA, Ortega P, Aramendi T, González C, Alberdi JM, et al. Melanoma colorrectal: revisión de dos formas diferentes de presentación. Gastroenterol Hepatol 2011;34:83-8.         [ Links ]

4. Heeney A, Mulsow J, Hyland J. Treatment and outcomes of anorectal melanoma. The Surgeon 2011;9:27-32.         [ Links ]

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License